FDA Approved: * July 24, 2020
Pharm Company: * AMNEAL
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Metyrosine Overview

Metirosine (INN and BAN; α-Methyltyrosine, Metyrosine USAN, AMPT) is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis, which, as a consequence, depletes the levels of the catecholamines dopamine, adrenaline and noradrenaline in the body. It is available as a generic medication.[1] Contents 1 Clinical use 2 See also 3 References 4 External links Clinical use Metirosine has been shown to suppress catecholam...

Read more Metyrosine Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Metyrosine Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Metyrosine: (3 results)

Sorted by National Drug Code
  • 60219-1621 Metyrosine 250 mg Oral Capsule by Amneal Pharmaceuticals Ny LLC
  • 68682-310 Metyrosine 250 mg Oral Capsule by Oceanside Pharmaceuticals
  • 69238-1621 Metyrosine 250 mg Oral Capsule by Amneal Pharmaceuticals Ny LLC

Other drugs which contain Metyrosine or a similar ingredient: (1 result)